Stocks and Investing
Stocks and Investing
Tue, January 30, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Laura Chico Reiterated (ATXS) at Buy and Held Target at $17 on, Jan 30th, 2024
Laura Chico of Wedbush, Reiterated "Astria Therapeutics, Inc." (ATXS) at Buy and Held Target at $17 on, Jan 30th, 2024.
Laura has made no other calls on ATXS in the last 4 months.
There are 2 other peers that have a rating on ATXS. Out of the 2 peers that are also analyzing ATXS, 0 agree with Laura's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Laura
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Wednesday, November 15th, 2023
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Thursday, October 12th, 2023
Contributing Sources